Scholarlink

<p>The convergence of genome editing and sustainability has positioned CRISPR-Cas technologies as transformative tools across agriculture and pharmacy. In crop protection, CRISPR-based diagnostics and resistance breeding are advancing sustainable strategies to mitigate plant diseases, reduce chemical pesticide use, and enhance food security. In parallel, CRISPR-Cas systems are accelerating the discovery and biosynthesis of plant-derived natural products with pharmaceutical relevance, offering greener pathways for drug development and functional foods. Miniature CRISPR effectors further expand the potential of portable, low-resource diagnostic platforms, strengthening applications in both field-based plant health monitoring and clinical settings. By integrating agricultural biotechnology with pharmaceutical innovation, CRISPR-Cas systems contribute to a circular bioeconomy and a sustainable future for global health. This review synthesizes recent advances, challenges, and opportunities at the interface of plant science and pharmacy, providing a roadmap for the next generation of sustainable biotechnology.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Advancing sustainable biotechnology through CRISPR-Cas applications in crop protection natural product discovery and pharmacy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月25日

查看全文
  • Himanshu Saini,
  • Jyoti Yadav,
  • Amita Yadav,
  • Sharad Sachan,
  • Atin Kumar

摘要

The convergence of genome editing and sustainability has positioned CRISPR-Cas technologies as transformative tools across agriculture and pharmacy. In crop protection, CRISPR-based diagnostics and resistance breeding are advancing sustainable strategies to mitigate plant diseases, reduce chemical pesticide use, and enhance food security. In parallel, CRISPR-Cas systems are accelerating the discovery and biosynthesis of plant-derived natural products with pharmaceutical relevance, offering greener pathways for drug development and functional foods. Miniature CRISPR effectors further expand the potential of portable, low-resource diagnostic platforms, strengthening applications in both field-based plant health monitoring and clinical settings. By integrating agricultural biotechnology with pharmaceutical innovation, CRISPR-Cas systems contribute to a circular bioeconomy and a sustainable future for global health. This review synthesizes recent advances, challenges, and opportunities at the interface of plant science and pharmacy, providing a roadmap for the next generation of sustainable biotechnology.

Graphical abstract